Ari Dumeciyan

Senior Director Of Accounting And Reporting at Tessera Therapeutics

Ari Dumeciyan, CPA has a strong background in accounting and financial reporting. They have worked in various roles, starting with PwC as an Audit Senior and progressing to Audit Manager at Ernst & Young. At Ernst & Young, they provided assurance services to public and non-public clients, including financial statement audits and audits of internal controls.

In 2012, Ari joined KPMG US as a Director in the Accounting Advisory Services department. In this role, they led technical accounting advisory services for public and private companies in various industries, including biotech/life science, manufacturing, and financial services. They provided guidance on complex transactions such as mergers and acquisitions, focusing on accounting policy alignment and SEC pro-forma reporting requirements.

In 2020, Ari moved to Anika as the Director of SEC Reporting and Technical Accounting. They were responsible for preparing the company's annual and quarterly filings with the SEC, collaborating with different teams and monitoring emerging accounting standards and reporting rules.

Currently, Ari holds the position of Senior Director of Accounting and Reporting at Tessera Therapeutics, where they oversee monthly close and external reporting, payroll, equity award administration, and internal controls.

Overall, Ari Dumeciyan's work experience showcases their expertise in accounting, financial reporting, technical advisory services, and SEC compliance.

Ari Dumeciyan, CPA holds a Bachelor's Degree in Economics from Istanbul University. Additionally, Ari is a Certified Public Accountant (CPA) in the states of Massachusetts, Illinois, and New Hampshire.

Location

Boston, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Tessera Therapeutics

3 followers

Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.


Industries

Employees

11-50

Links